Q4 2025 Holdings
Filed 2026-02-17 | 78 holdings | $583.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $52.8M | 391,783 | 9.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $39.1M | 886,893 | 6.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $28.9M | 1,154,114 | 4.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $28.1M | 1,339,379 | 4.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $24.4M | 351,073 | 4.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $21.7M | 332,860 | 3.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $21.0M | 966,698 | 3.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $17.3M | 429,198 | 3.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $16.4M | 518,355 | 2.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $16.4M | 644,959 | 2.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $16.3M | 835,200 | 2.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.6M | 348,605 | 2.7% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $12.7M | 619,766 | 2.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $11.8M | 118,333 | 2.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $10.5M | 290,049 | 1.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $10.3M | 17,736 | 1.8% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $9.9M | 606,825 | 1.7% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $9.9M | 4,192,375 | 1.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.3M | 146,978 | 1.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.0M | 360,876 | 1.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $7.6M | 97,340 | 1.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $7.5M | 178,274 | 1.3% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $7.2M | 35,000 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $6.9M | 419,058 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.8M | 565,140 | 1.2% |
| Clearpoint Neuro Inc(CLPT) | COM | 18507C103 | $6.6M | 481,858 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.5M | 224,740 | 1.1% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $6.5M | 353,849 | 1.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $6.4M | 610,308 | 1.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $6.3M | 522,693 | 1.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $6.3M | 58,915 | 1.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $6.2M | 21,067 | 1.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $6.1M | 80,574 | 1.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.1M | 61,435 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $5.6M | 161,659 | 1.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $5.3M | 156,728 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $5.2M | 125,877 | 0.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.2M | 59,430 | 0.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $5.1M | 4,759 | 0.9% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.0M | 399,557 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.9M | 62,032 | 0.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.8M | 154,320 | 0.8% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $4.7M | 986,751 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.6M | 348,401 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.4M | 1,036,311 | 0.8% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $3.6M | 898,465 | 0.6% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $3.5M | 1,458,807 | 0.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $3.3M | 79,284 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.2M | 14,842 | 0.5% |
| Repligen Corp(RGEN) | COM | 759916109 | $2.6M | 15,707 | 0.4% |